This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Apr;365(9466):1230.

doi: 10.1016/S0140-6736(05)74810-8.

LRRK2 mutations and Parkinsonism

PMID: 15811455
DOI: 10.1016/S0140-6736(05)74810-8

Comment

LRRK2 mutations and Parkinsonism

Mario Albrecht. Lancet. 2005 Apr.

. 2005 Apr;365(9466):1230.

doi: 10.1016/S0140-6736(05)74810-8.

Author

PMID: 15811455
DOI: 10.1016/S0140-6736(05)74810-8

No abstract available

PubMed Disclaimer

Comment on

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.
Nichols WC, Pankratz N, Hernandez D, Paisán-Ruíz C, Jain S, Halter CA, Michaels VE, Reed T, Rudolph A, Shults CW, Singleton A, Foroud T; Parkinson Study Group-PROGENI investigators. Nichols WC, et al. Lancet. 2005 Jan 29-Feb 4;365(9457):410-2. doi: 10.1016/S0140-6736(05)17828-3. Lancet. 2005. PMID: 15680455
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.
Di Fonzo A, Rohé CF, Ferreira J, Chien HF, Vacca L, Stocchi F, Guedes L, Fabrizio E, Manfredi M, Vanacore N, Goldwurm S, Breedveld G, Sampaio C, Meco G, Barbosa E, Oostra BA, Bonifati V; Italian Parkinson Genetics Network. Di Fonzo A, et al. Lancet. 2005 Jan 29-Feb 4;365(9457):412-5. doi: 10.1016/S0140-6736(05)17829-5. Lancet. 2005. PMID: 15680456
A common LRRK2 mutation in idiopathic Parkinson's disease.
Gilks WP, Abou-Sleiman PM, Gandhi S, Jain S, Singleton A, Lees AJ, Shaw K, Bhatia KP, Bonifati V, Quinn NP, Lynch J, Healy DG, Holton JL, Revesz T, Wood NW. Gilks WP, et al. Lancet. 2005 Jan 29-Feb 4;365(9457):415-6. doi: 10.1016/S0140-6736(05)17830-1. Lancet. 2005. PMID: 15680457

Similar articles

LRRK2 mutations and Parkinsonism.
Toft M, Mata IF, Kachergus JM, Ross OA, Farrer MJ. Toft M, et al. Lancet. 2005 Apr 2-8;365(9466):1229-30. doi: 10.1016/S0140-6736(05)74809-1. Lancet. 2005. PMID: 15811454 No abstract available.
Re: The G2019S LRRK2 mutation is uncommon amongst Greek patients with familial Parkinson's disease.
Papapetropoulos S, Argyriou AA, Mitsi G, Chroni E. Papapetropoulos S, et al. Eur J Neurol. 2007 Nov;14(11):e6. doi: 10.1111/j.1468-1331.2007.01933.x. Eur J Neurol. 2007. PMID: 17956439 No abstract available.
The importance of LRRK2 mutations in Parkinson disease.
Schapira AH. Schapira AH. Arch Neurol. 2006 Sep;63(9):1225-8. doi: 10.1001/archneur.63.9.1225. Arch Neurol. 2006. PMID: 16966498 Review. No abstract available.
Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation.
Deng H, Le W, Guo Y, Hunter CB, Xie W, Jankovic J. Deng H, et al. Ann Neurol. 2005 Jun;57(6):933-4. doi: 10.1002/ana.20510. Ann Neurol. 2005. PMID: 15929036 No abstract available.
Mutations in LRRK2 as a cause of Parkinson's disease.
Giasson BI, Van Deerlin VM. Giasson BI, et al. Neurosignals. 2008;16(1):99-105. doi: 10.1159/000109764. Epub 2007 Dec 5. Neurosignals. 2008. PMID: 18097165 Review.

See all similar articles

Cited by

The genetic epidemiology of neurodegenerative disease.
Bertram L, Tanzi RE. Bertram L, et al. J Clin Invest. 2005 Jun;115(6):1449-57. doi: 10.1172/JCI24761. J Clin Invest. 2005. PMID: 15931380 Free PMC article. Review.
α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.
Covy JP, Giasson BI. Covy JP, et al. Neurotoxicology. 2011 Oct;32(5):622-9. doi: 10.1016/j.neuro.2011.01.003. Epub 2011 Jan 14. Neurotoxicology. 2011. PMID: 21238487 Free PMC article. Review.
Genetic animal models of Parkinson's disease.
Dawson TM, Ko HS, Dawson VL. Dawson TM, et al. Neuron. 2010 Jun 10;66(5):646-61. doi: 10.1016/j.neuron.2010.04.034. Neuron. 2010. PMID: 20547124 Free PMC article. Review.
Structural assessment of the effects of amino acid substitutions on protein stability and protein protein interaction.
Teng S, Srivastava AK, Schwartz CE, Alexov E, Wang L. Teng S, et al. Int J Comput Biol Drug Des. 2010;3(4):334-49. doi: 10.1504/IJCBDD.2010.038396. Epub 2011 Feb 4. Int J Comput Biol Drug Des. 2010. PMID: 21297231 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information